Complications Related to Access Site After Percutaneous Coronary Interventions: Are the Adverse Events Underreported?

被引:10
作者
Crudu, Vitalie [1 ]
Blankenship, James [1 ]
Berger, Peter [2 ]
Scott, Thomas [1 ]
Skelding, Kimberly [1 ]
机构
[1] Geisinger Med Ctr, Dept Cardiol, Danville, PA 17822 USA
[2] Geisinger Ctr Hlth Res, Danville, PA USA
关键词
NCDR; QI; PCI; VASCULAR COMPLICATIONS;
D O I
10.1002/ccd.22759
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The primary objective was to compare the NCDR rate of four access site related complications (arteriovenous fistula, pseudoaneurysm, retroperitoneal bleed, and blood transfusion) with that obtained independently within a Quality Improvement (QI) Database. The secondary objective was to determine the in-hospital mortality related to these complications. Background: NCDR is the most comprehensive database of post-PCI patients and a method by which hospitals are compared for quality of care and outcomes. The collected data include in-hospital events only, therefore reporting for same day and/or early discharges may fail to capture adverse events. We hypothesized that the actual rate of complications post-PCI may be higher than the rate reported in NCDR. Methods: Adverse events following PCIs were collected in a QI database. We compared the rate of four abovementioned complications between NCDR and our QI database for the time period between January 1, 2005 and December 31, 2008. Results: A total of 3,940 PCIs were performed on 3,430 patients in the four-year interval. The incidence of the combined endpoint of the four adverse events was 4.1% (161 events) in NCDR, vs. 4.7% (186 events) in QI database, a 13% higher yield. There was significantly higher in-hospital mortality in the complication group with regards to both all cause (4.7% vs. 1.1%, P < 0.0001) and cardiovascular mortality (2.7% vs. 1%, P = 0.046). Conclusions: Access site related complications occurred 13% more than what was reported in NCDR and were associated with a greater than fourfold increase in in-hospital mortality. (C) 2011 Wiley-Liss, Inc.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 13 条
[1]   A contemporary overview of percutaneous coronary interventions - The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) [J].
Anderson, HV ;
Shaw, RE ;
Brindis, RG ;
Hewitt, K ;
Krone, RJ ;
Block, PC ;
McKay, CR ;
Weintraub, WS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1096-1103
[2]   Trends in Vascular Complications After Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention Via the Femoral Artery, 1998 to 2007 [J].
Applegate, Robert J. ;
Sacrinty, Matthew T. ;
Kutcher, Michael A. ;
Kahl, Frederic R. ;
Gandhi, Sanjay K. ;
Santos, Renato M. ;
Little, William C. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (03) :317-326
[3]   Major Femoral Bleeding Complications After Percutaneous Coronary Intervention Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005 [J].
Doyle, Brendan J. ;
Ting, Henry H. ;
Bell, Malcolm R. ;
Lennon, Ryan J. ;
Mathew, Verghese ;
Singh, Mandeep ;
Holmes, David R. ;
Rihal, Charanjit S. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (02) :202-209
[4]   The economic burden of complications during percutaneous coronary intervention [J].
Jacobson, Kurt M. ;
Long, Kirsten Hall ;
McMurtry, Erin K. ;
Naessens, James M. ;
Rihal, Charanjit S. .
QUALITY & SAFETY IN HEALTH CARE, 2007, 16 (02) :154-159
[5]   Hospital resources consumed in treating complications associated with percutaneous coronary interventions [J].
Kugelmass, AD ;
Cohen, DJ ;
Brown, PP ;
Simon, AW ;
Becker, ER ;
Culler, SD .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (03) :322-327
[6]   Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization - REPLACE-2 randomized trial [J].
Lincoff, AM ;
Kleiman, NS ;
Kereiakes, DJ ;
Feit, F ;
Bittl, JA ;
Jackman, JD ;
Sarembock, IJ ;
Cohen, DJ ;
Spriggs, D ;
Ebrahimi, R ;
Keren, G ;
Carr, J ;
Cohen, EA ;
Betriu, A ;
Desmet, W ;
Rutsch, W ;
Wilcox, RG ;
de Feyter, PJ ;
Vahanian, A ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (06) :696-703
[7]   Bleeding in Patients Undergoing Percutaneous Coronary Intervention The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry [J].
Mehta, Sameer K. ;
Frutkin, Andrew D. ;
Lindsey, Jason B. ;
House, John A. ;
Spertus, John A. ;
Rao, Sunil V. ;
Ou, Fang-Shu ;
Roe, Matthew T. ;
Peterson, Eric D. ;
Marso, Steven P. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (03) :222-U107
[8]   Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions [J].
Moscucci, M ;
Rogers, EK ;
Montoye, C ;
Smith, DE ;
Share, D ;
O'Donnell, M ;
Maxwell-Eward, A ;
Meengs, WL ;
De Franco, AC ;
Patel, K ;
McNamara, R ;
McGinnity, JG ;
Jani, SM ;
Khanal, S ;
Eagle, KA .
CIRCULATION, 2006, 113 (06) :814-822
[9]   Predicting vascular complications in percutaneous coronary interventions [J].
Piper, WD ;
Malenka, DJ ;
Ryan, TJ ;
Shubrooks, SJ ;
O'Connor, GT ;
Robb, JF ;
Farrell, KL ;
Corliss, MS ;
Hearne, MJ ;
Kellett, MA ;
Watkins, MW ;
Bradley, WA ;
Hettleman, BD ;
Silver, TM ;
McGrath, PD ;
O'Mears, JR ;
Wennberg, DE .
AMERICAN HEART JOURNAL, 2003, 145 (06) :1022-1029
[10]  
Rihal CS, 2006, AM J MANAG CARE, V12, P445